HemaSphere (Jun 2022)
P453: CDK6 DEGRADATION IS IMPEDED BY P16INK4A AND P18INK4C IN AML
- B. Schmalzbauer,
- T. Thondanpallil,
- G. Heller,
- C.-M. Sperl,
- I. M. Mayer,
- V. M. Knab,
- S. Nebenfuehr,
- M. Zojer,
- A. C. Mueller,
- F. Fontaine,
- T. Klampfl,
- V. Sexl,
- K. Kollmann
Affiliations
- B. Schmalzbauer
- 1 Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna
- T. Thondanpallil
- 1 Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna
- G. Heller
- 2 Department of Medicine I, Division of Oncology, Medical University of Vienna
- C.-M. Sperl
- 1 Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna
- I. M. Mayer
- 1 Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna
- V. M. Knab
- 1 Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna
- S. Nebenfuehr
- 1 Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna
- M. Zojer
- 1 Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna
- A. C. Mueller
- 3 CeMM – Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
- F. Fontaine
- 3 CeMM – Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
- T. Klampfl
- 1 Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna
- V. Sexl
- 1 Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna
- K. Kollmann
- 1 Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna
- DOI
- https://doi.org/10.1097/01.HS9.0000844700.47841.7f
- Journal volume & issue
-
Vol. 6
pp. 353 – 354
Abstract
No abstracts available.